Get the content you want anytime you want.
REGISTER NOW | SIGN IN
VIDEO

What Makes ABSSSI Antibiotic Iclaprim Unique?

SEP 22, 2017 | CONTAGION® EDITORIAL STAFF


William D. O’Riordan, MD, FACEP, chief medical officer, eStudySite, explains how iclaprim has a unique mechanism of action, making it a unique antibiotic to treat acute bacterial skin and skin structure infections. Dr. O’Riordan explains how dihydrofolate reductase interferes with an enzyme that is involved with the bacterial cell and essentially “does away” with it.
To stay informed on the latest in infectious disease news and developments, please sign up for our weekly newsletter.


FEATURED
Big advances in treatment can